Qosina hires new representative for Korean market

高管变更
Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, announces the addition of David Oh as the new representative for the Korean market. Oh brings over two decades of experience to his new role, having been actively involved in the medical device industry since graduating from Penn State University in 2000. One of Oh's strengths lies in his ability to navigate regulatory matters, particularly with the Ministry of Food and Drug Safety (MFDS). Oh is hoping his experience in developing policies to handle regulatory affairs will help the Qosina customer move towards compliance with standards and regulations. Oh also has experience in developing quality control strategies essential for maintaining MFDS approvals and advising customers on the requirements set forth by the Korea Medical Device Industry Association (KMDIA). “We are thrilled to welcome David Oh to the Qosina family,” said Jeff Cushner, vice president of sales at Qosina. “His extensive experience and expertise make him an invaluable asset to our team as we continue to expand our presence in the Korean market. We are confident that David will provide unparalleled support and solutions in Korea.”
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。